AYAConnect
Phase NA Completed
63 enrolled
HERO
Phase NA Completed
113 enrolled
ROOT
Completed
167 enrolled
CPI-006 Alone and in Combination With Ciforadenant and With Pembrolizumab for Patients With Advanced Cancers
Phase 1 Completed
117 enrolled
Study of A166 in Patients With Relapsed/Refractory Cancers Expressing HER2 Antigen or Having Amplified HER2 Gene
Phase 1/2 Completed
49 enrolled
Physician-Initiated Stop-Smoking Program for Patients Receiving Treatment for Early-Stage Cancer
Phase NA Completed
434 enrolled
GASVERT
Phase 3 Completed
744 enrolled
A Volume, Motion, and Anatomically Adaptive Approach to Photon and Proton Beam Radiotherapy
Phase NA Completed
74 enrolled 8 charts
RAV12 in Treating Patients With Metastatic or Recurrent Adenocarcinoma
Phase 1 Completed
53 enrolled
ONCODAGE
Phase NA Completed
1,674 enrolled 9 charts
Effects of High-intensity Training Compared to Resistance Training in Cancer Patients Undergoing Radiotherapy
Phase NA Completed
78 enrolled
ADCC
Phase 1 Completed
24 enrolled
18F-FPPRGD2 PET/CT or PET/MRI in Predicting Early Response in Patients With Cancer Receiving Anti-Angiogenesis Therapy
Phase 1/2 Completed
25 enrolled 14 charts
EPAC
Phase NA Completed
213 enrolled 20 charts
Quality of Life in Patients Undergoing Radiation Therapy for Primary Lung Cancer, Head and Neck Cancer, or Gastrointestinal Cancer
Completed
144 enrolled
Spectroscopy With Surface Coils and Decoupling
Phase 1 Completed
582 enrolled
Erlotinib Hydrochloride and Cetuximab in Treating Patients With Advanced Gastrointestinal Cancer, Head and Neck Cancer, Non-Small Cell Lung Cancer, or Colorectal Cancer
Phase 1 Completed
43 enrolled
Vaccine Therapy in Treating Patients With Advanced or Metastatic Cancer
Phase 1 Completed
14 enrolled
Erlotinib and Cetuximab With or Without Bevacizumab in Treating Patients With Metastatic or Unresectable Kidney, Colorectal, Head and Neck, Pancreatic, or Non-Small Cell Lung Cancer
Phase 1/2 Completed
66 enrolled
Fentanyl Sublingual Spray in Treating Patients With Breakthrough Cancer Pain
Phase 3 Completed
130 enrolled 9 charts
7-Hydroxystaurosporine and Irinotecan Hydrochloride in Treating Patients With Metastatic or Unresectable Solid Tumors or Triple Negative Breast Cancer (Currently Accruing Only Triple-negative Breast Cancer Patients Since 6/8/2007)
Phase 1 Completed
41 enrolled
HX4-200
Phase 2 Completed
50 enrolled 7 charts
Chemotherapy in Treating Patients With Solid Tumors
Phase 1/2 Completed
57 enrolled
Oxaliplatin in Treating Young Patients With Recurrent Solid Tumors That Have Not Responded to Previous Treatment
Phase 2 Completed
180 enrolled
Growth Factor Levels in the Blood of Patients Undergoing Radiation Therapy for Epithelial Cancer
Completed
25 enrolled
Immunoreactivity to Cetuximab in Cancer Patients
Completed
538 enrolled
Interleukin-12 and Trastuzumab in Treating Patients With Cancer That Has High Levels of HER2/Neu
Phase 1 Completed
15 enrolled
Biological Therapy in Treating Patients With Metastatic Cancer
Phase 1 Completed
24 enrolled
Trastuzumab Plus R115777 in Treating Patients With Advanced or Metastatic Cancer
Phase 1 Completed
24 enrolled
Vaccine Therapy With or Without Sargramostim in Treating Patients With Advanced or Metastatic Cancer
Phase 1 Completed
48 enrolled
Erlotinib in Treating Patients With Solid Tumors and Liver or Kidney Dysfunction
Phase 1 Completed
75 enrolled
MS-275 in Treating Patients With Advanced Solid Tumors or Lymphoma
Phase 1 Completed
75 enrolled
Boronophenylalanine-Fructose Complex (BPA-F) and/or Sodium Borocaptate (BSH) Followed By Surgery in Treating Patients With Thyroid Cancer, Head and Neck Cancer, or Liver Metastases
Phase 1 Completed
27 enrolled
Gene Therapy in Treating Patients With Cancer
Phase 1 Completed
Thalidomide and Docetaxel in Treating Patients With Advanced Cancer
Phase 1 Completed
26 enrolled
Photodynamic Therapy System for Patients With Refractory/Unresponsive Solid Tumors
Phase 1 Completed
48 enrolled